Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Clinical Report on Efficacy of Alternative European Viper Antivenoms in Treatment of <i>Vipera ammodytes</i> Envenomation in Croatia.

Toxins·2026
Same author

Lactoferrin and Its Enzymatic Hydrolysates as Natural Antimicrobial and Antioxidant Agents for Food Preservation.

Foods (Basel, Switzerland)·2026
Same author

Current Status of Molecular Dynamics Simulations of Membrane Permeabilization by Antimicrobial Peptides and Pore-Forming Proteins: A Review.

Journal of chemical information and modeling·2026
Same author

Gassericins from Lactobacillus Paragasseri K7: Preparative Isolation and Discovery of Dose-Dependent Anti-Inflammatory Effects.

Probiotics and antimicrobial proteins·2026
Same author

Species-specific structural adaptation of the potyviral coat protein in virions and virus-like particles.

Communications biology·2026
Same author

Venom-Induced Recurrent Thrombocytopenia: A Model of Intervention-Driven Platelet Modulation.

Toxins·2025

Related Experiment Video

Updated: Jun 4, 2026

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
10:31

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2

Published on: September 26, 2025

Haemostatically active proteins in snake venoms.

Tamara Sajevic1, Adrijana Leonardi, Igor Križaj

  • 1Department of Molecular and Biomedical Sciences, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia.

Toxicon : Official Journal of the International Society on Toxinology
|February 1, 2011
PubMed
Summary
This summary is machine-generated.

Snake venom proteins impact blood clotting, causing bleeding or thrombosis. Some venom proteins are medically valuable for treating hemostatic disorders, with more potential applications emerging.

More Related Videos

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production
05:27

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production

Published on: October 6, 2023

Related Experiment Videos

Last Updated: Jun 4, 2026

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
10:31

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2

Published on: September 26, 2025

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production
05:27

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production

Published on: October 6, 2023

Area of Science:

  • Biochemistry and Pharmacology of Natural Products
  • Hemostasis and Thrombosis Research
  • Toxicology and Toxinology

Background:

  • Snake venom contains diverse proteins that significantly influence the hemostatic system.
  • These proteins can induce effects ranging from reduced blood coagulability to thrombosis.
  • Understanding these venom components is crucial for both basic science and clinical applications.

Purpose of the Study:

  • To review key haemostatically active protein families from snake venoms.
  • To survey both enzymatic and non-enzymatic effectors of hemostasis.
  • To discuss current and potential medical applications of these venom proteins.

Main Methods:

  • Literature review of scientific data on snake venom proteins affecting hemostasis.
  • Categorization of proteins into enzymatic (proteinases, phospholipases A₂, L-amino acid oxidases, 5'-nucleotidases) and non-enzymatic (disintegrins, C-type lectins, three-finger toxins) groups.
  • Analysis of approved drugs and diagnostic tools derived from these venom components.

Main Results:

  • Identified several classes of snake venom proteins that profoundly affect blood coagulation, vascular integrity, and thrombosis.
  • Highlighted specific enzymes and non-enzymes with known roles in hemostasis, including proteinases, phospholipases A₂, L-amino acid oxidases, 5'-nucleotidases, disintegrins, C-type lectins, and three-finger toxins.
  • Documented existing medical uses for some snake venom proteins in treating hemostatic disorders and diagnostics.

Conclusions:

  • Snake venom proteins represent a rich source of compounds with significant hemostatic activity.
  • While some proteins have found clinical application, the majority await exploration for therapeutic potential.
  • Further research into these venom components holds promise for developing novel treatments for bleeding and clotting disorders.